ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

IKT Inhibikase Therapeutics Inc

1,39
0,05 (3,73%)
04 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Inhibikase Therapeutics Inc IKT NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,05 3,73% 1,39 01:00:10
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
1,38 1,3304 1,51 1,39 1,34
mais cotações »

Notícias Recentes

Data Hora Fonte Título
18/04/202417:30GLOBEInhibikase Therapeutics Issues Letter to Shareholders and..
03/04/202409:05GLOBEInhibikase Therapeutics Announces Pre-IND Meeting with the..
27/03/202417:15GLOBEInhibikase Therapeutics Reports Fourth Quarter and Full Year..
07/03/202410:30GLOBEInhibikase Therapeutics to Provide Trial Update for..
28/02/202418:05GLOBEInhibikase Therapeutics Announces Full Outcomes of its..
07/02/202409:55GLOBEInhibikase Therapeutics Announces Preliminary Outcomes of..
29/01/202411:05GLOBEInhibikase Therapeutics Announces Publication Highlighting..
16/01/202418:05GLOBEInhibikase Therapeutics Announces Planned Retirement of..
19/12/202310:30GLOBEInhibikase Therapeutics Issues Letter to Shareholders and..
04/12/202310:35GLOBEInhibikase Therapeutics Granted Pre-NDA Meeting with the FDA..
14/11/202318:30GLOBEInhibikase Therapeutics Reports Third Quarter Financial..
07/11/202311:28GLOBECorrecting & Replacing -- Inhibikase Therapeutics to Report..
07/11/202310:00GLOBEInhibikase Therapeutics to Report Second Quarter Financial..
16/10/202308:00GLOBEInhibikase Therapeutics Highlights Unblinded Functional..
04/10/202309:30GLOBEInhibikase Therapeutics Receives FDA Orphan Drug Designation..
24/08/202309:30PRNUSInhibikase Therapeutics Announces Development of Novel..
22/08/202309:05PRNUSInhibikase Therapeutics to Present at the International..
21/08/202309:30PRNUSInhibikase Therapeutics Initiates Development of Second..
17/08/202309:30PRNUSInhibikase Therapeutics Announces Completion of the 501..
14/08/202317:20PRNUSInhibikase Therapeutics Reports Second Quarter Financial..
07/08/202309:05PRNUSInhibikase Therapeutics to Report Second Quarter Financial..
17/07/202317:05PRNUSInhibikase Therapeutics Regains Compliance with Nasdaq..
29/06/202310:29PRNUSInhibikase Therapeutics Announces a 1-for-6 Reverse Stock..
22/06/202309:05PRNUSInhibikase Therapeutics Announces Selection of the..
21/06/202309:05PRNUSInhibikase Therapeutics Initiates Medical and Patient..
30/05/202309:05PRNUSInhibikase Therapeutics to Present at the LD Micro..
16/05/202308:45PRNUSInhibikase Therapeutics Announces Dosing of First Patient in..
15/05/202309:30PRNUSInhibikase Therapeutics Reports First Quarter Financial..
08/05/202309:05PRNUSInhibikase Therapeutics to Report First Quarter Financial..

Seu Histórico Recente

Delayed Upgrade Clock